X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10665) 10665
Publication (957) 957
Newsletter (602) 602
Newspaper Article (455) 455
Book Review (293) 293
Book / eBook (174) 174
Magazine Article (146) 146
Dissertation (117) 117
Book Chapter (116) 116
Trade Publication Article (72) 72
Transcript (18) 18
Conference Proceeding (17) 17
Reference (6) 6
Data Set (3) 3
Report (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8438) 8438
hiv infections - drug therapy (5892) 5892
hiv (4787) 4787
male (4440) 4440
female (4164) 4164
index medicus (3987) 3987
adult (3935) 3935
infectious diseases (3151) 3151
human immunodeficiency virus--hiv (2841) 2841
middle aged (2752) 2752
drug therapy (2480) 2480
protease inhibitors (2471) 2471
antiretroviral therapy (2350) 2350
hiv protease inhibitors - adverse effects (2262) 2262
hiv infection (2232) 2232
anti-hiv agents - therapeutic use (2189) 2189
anti-hiv agents - adverse effects (2127) 2127
aids (2102) 2102
antiviral agents (1945) 1945
immunology (1847) 1847
hiv infections - complications (1750) 1750
risk factors (1723) 1723
pharmacology & pharmacy (1704) 1704
highly active antiretroviral therapy (1699) 1699
antiretroviral drugs (1688) 1688
health aspects (1606) 1606
research (1587) 1587
hiv protease inhibitors - therapeutic use (1559) 1559
drug therapy, combination (1531) 1531
virology (1365) 1365
human-immunodeficiency-virus (1303) 1303
hiv patients (1265) 1265
acquired immune deficiency syndrome--aids (1248) 1248
care and treatment (1231) 1231
viral load (1212) 1212
treatment outcome (1188) 1188
antiretroviral therapy, highly active - adverse effects (1186) 1186
human immunodeficiency virus (1175) 1175
hiv infections - virology (1124) 1124
cd4 lymphocyte count (1114) 1114
therapy (1049) 1049
active antiretroviral therapy (956) 956
drug interactions (937) 937
anti-hiv agents - administration & dosage (924) 924
antiretroviral therapy, highly active (915) 915
hiv-1 (903) 903
medicine (900) 900
infection (879) 879
microbiology (853) 853
hiv-1 - drug effects (845) 845
hiv protease inhibitors - administration & dosage (835) 835
ritonavir - adverse effects (833) 833
research article (829) 829
ritonavir (825) 825
infections (818) 818
reverse transcriptase inhibitors - therapeutic use (795) 795
reverse transcriptase inhibitors - adverse effects (787) 787
adolescent (753) 753
medicine, general & internal (747) 747
dosage and administration (719) 719
hiv-infected patients (715) 715
virus diseases (708) 708
aged (688) 688
lipodystrophy (688) 688
hiv infections - immunology (683) 683
patients (672) 672
ritonavir - therapeutic use (659) 659
proteases (658) 658
analysis (651) 651
acquired immune deficiency syndrome (650) 650
animals (647) 647
aids/hiv (646) 646
mortality (641) 641
pharmacokinetics (631) 631
complications and side effects (623) 623
clinical trials (619) 619
anti-hiv agents (616) 616
medical research (593) 593
prospective studies (577) 577
infected patients (576) 576
cohort studies (566) 566
retrospective studies (562) 562
antiretroviral agents (556) 556
hiv infections - epidemiology (554) 554
ritonavir - administration & dosage (554) 554
tenofovir (551) 551
young adult (551) 551
multidisciplinary sciences (546) 546
studies (546) 546
science (542) 542
drugs (540) 540
efavirenz (539) 539
pregnancy (538) 538
prevalence (534) 534
drug resistance (513) 513
usage (512) 512
drug administration schedule (511) 511
lopinavir (507) 507
protease inhibitor (500) 500
hiv-1-infected patients (495) 495
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (126) 126
Collection Dvlpm't (Acquisitions) - Closed Orders (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
UofT at Scarborough - Stacks (10) 10
UofT at Mississauga - Stacks (9) 9
New College (Ivey) - Stacks (8) 8
Robarts - Stacks (7) 7
Online Resources - Online (4) 4
Toronto East General Hospital - Stacks (4) 4
Credit Valley Hospital - Stacks (3) 3
Gerstein Science - Reference (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
St. Michael's Hospital - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
New College (Ivey) - Reserve desk (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Missing (1) 1
Law (Bora Laskin) - Stacks (1) 1
Media Commons - Microtexts (1) 1
OISE - Theses (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11854) 11854
Spanish (183) 183
German (112) 112
French (92) 92
Italian (16) 16
Portuguese (14) 14
Danish (12) 12
Dutch (11) 11
Japanese (11) 11
Turkish (7) 7
Norwegian (4) 4
Russian (4) 4
Swedish (4) 4
Korean (3) 3
Polish (3) 3
Serbian (2) 2
Afrikaans (1) 1
Chinese (1) 1
Czech (1) 1
Hebrew (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2008, Volume 197, Issue 1, pp. 102 - 108
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 6, pp. 2047 - 2055
Background & Aims Therapeutic regimens are being developed for patients with hepatitis C virus (HCV) infection that do not include the combination of... 
Gastroenterology and Hepatology | Drug | Peginterferon-Free | Direct-Acting Antivirals | Clinical Trial | ANTIVIRAL AGENTS | VIROLOGICAL RESPONSE SVR | CHRONIC HEPATITIS-C | IN-VITRO | THERAPY | PEGINTERFERON ALPHA-2A | COMBINATION TREATMENT | RESISTANCE | GENOTYPE 1 INFECTION | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Acrylates - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA Replicase - antagonists & inhibitors | RNA, Viral - blood | Thiazoles - therapeutic use | Oligopeptides - adverse effects | Thiazoles - adverse effects | Viral Load | Acrylates - adverse effects | Oligopeptides - therapeutic use | Protease Inhibitors - adverse effects | Female | Benzimidazoles - adverse effects | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | RNA, Viral - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Complications and side effects | Antiviral agents | Care and treatment | Protease inhibitors | Proteases | Universities and colleges | Hepatitis C | Hepatitis C virus | Ribavirin | Anti-HIV agents
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 7, pp. 630 - 639
Journal Article
AIDS, ISSN 0269-9370, 07/2010, Volume 24, Issue 11, pp. 1697 - 1707
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 8, pp. 1241 - 1249
Background. Specific antiretroviral therapy (ART) medications and the severity of human immunodeficiency virus (HIV) disease before treatment contribute to... 
human immunodeficiency virus | bone mineral density | protease inhibitor | inflammation | integrase inhibitor | INTIMA-MEDIA THICKNESS | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | TURNOVER | EMTRICITABINE | MICROBIOLOGY | OSTEOPROTEGERIN | IMMUNOLOGY | HIV-INFECTED ADULTS | PROTEASE INHIBITORS | THERAPY | RECEPTOR ACTIVATOR | Raltegravir Potassium - adverse effects | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Male | Atazanavir Sulfate - adverse effects | HIV - drug effects | Viral Load | Reverse Transcriptase Inhibitors - adverse effects | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | HIV Protease Inhibitors - adverse effects | Emtricitabine - adverse effects | Emtricitabine - therapeutic use | Tenofovir - adverse effects | Tenofovir - therapeutic use | Anti-HIV Agents - adverse effects | HIV Protease Inhibitors - therapeutic use | Atazanavir Sulfate - therapeutic use | Bone Density - drug effects | HIV Integrase Inhibitors - adverse effects | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Darunavir - adverse effects | HIV Infections - physiopathology | Darunavir - therapeutic use | Antiviral agents | Care and treatment | Analysis | Bones | Dosage and administration | Inflammation | HIV infection | Density | Risk factors | Major and Brief Reports
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 9, pp. 717 - 728
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2012, Volume 55, Issue 9, pp. 1262 - 1269
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 20, pp. 2095 - 2106
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 01/2014, Volume 39, Issue 1, pp. 93 - 103
Summary Background Limited data exist on the effectiveness of boceprevir and telaprevir in routine practice. Aim To assess the comparative effectiveness of... 
SUSTAINED VIROLOGICAL RESPONSE | UNITED-STATES | SIMPLE NONINVASIVE INDEX | SIGNIFICANT FIBROSIS